Company / Shareholders' Equity
Incyte Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.2B
FY2025
5-year range
$3.4B / $5.2B
FY2021-FY2025
Trend
+49.9%
vs FY2024
Sector context
#19 of 213
Health Care
What the data says
Among 213 Health Care companies, Incyte is in the top 9% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $419M in FY2016 to $5.2B in FY2023.
Based on SEC 10-K filings.
$5.2B in FY2025 with a 5-year CAGR of +21.8%. Top quartile in the Health Care sector.
Remained stable around $5.2B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 213This company $5.2B Sector average $2.5B
▼
+102.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +21.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 49.9% year-over-year.
- Ranks #19 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2B | +49.9% |
| FY2024 | $3.4B | -33.6% |
| FY2023 | $5.2B | +18.8% |
| FY2022 | $4.4B | +15.9% |
| FY2021 | $3.8B | +95.7% |
| FY2020 | $1.9B | +18.1% |
| FY2019 | $1.6B | -15.3% |
| FY2018 | $1.9B | +18.1% |
| FY2017 | $1.6B | +288.7% |
| FY2016 | $419.5M | +145.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026